Los Angeles Capital Management LLC Karuna Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$176.32 - $240.22 $372,387 - $507,344	-2,112 Reduced 53.19%	1,859 $403,000
Q1 2023 May 04, 2023	SELL	$161.33 - $204.36 $77,438 - $98,092	-480 Reduced 10.78%	3,971 $721,000
Q4 2022 Feb 06, 2023	SELL	$191.53 - $236.82 $87,337 - $107,989	-456 Reduced 9.29%	4,451 $874,000
Q3 2022 Nov 02, 2022	BUY	$123.79 - $277.42 $607,437 - $1.36 Million	4,907 New	4,907 $1.1 Million
Q1 2021 May 05, 2021	SELL	$95.46 - $133.08 $274,924 - $383,270	-2,880 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$75.23 - $109.23 $11,284 - $16,384	-150 Reduced 4.95%	2,880 $293,000
Q3 2020 Nov 02, 2020	BUY	$71.31 - $109.74 $216,069 - $332,512	3,030 New	3,030 $234,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.